4//SEC Filing
GREEN DAVID 4
Accession 0001493152-23-006611
CIK 0001563665other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:00 PM ET
Size
10.4 KB
Accession
0001493152-23-006611
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
GREEN DAVID
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-28+38,773→ 38,773 totalExercise: $6.00Exp: 2033-02-28→ Common Stock, par value $0.01 per share (38,773 underlying) - Award
Stock Option (right to buy)
2023-02-28+732,384→ 732,384 totalExercise: $6.00Exp: 2033-02-28→ Common Stock, par value $0.01 per share (732,384 underlying) - Award
Stock Option (right to buy)
2023-02-28+39,662→ 39,662 totalExercise: $6.00Exp: 2033-02-28→ Common Stock, par value $0.01 per share (39,662 underlying)
Footnotes (3)
- [F1]This stock option grant was fully exercisable as of date of grant.
- [F2]The non-qualified stock option was scheduled to vest during the twelve months following the grant date, but in connection with the Issuer's transition to a new CEO as of March 1, 2023, this option has been forfeited.
- [F3]The non-qualified stock option was scheduled to vest monthly in thirty-six equal monthly installments on each monthly anniversary of February 28, 2023, but in connection with the Issuer's transition to a new CEO as of March 1, 2023, 488,256 shares underlying this option have been forfeited, and subject to the Reporting Person's execution of a customary release, the remaining 244,128 shares will be deemed fully vested and exercisable.
Documents
Issuer
Biostage, Inc.
CIK 0001563665
Entity typeother
Related Parties
1- filerCIK 0001008643
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 8:00 PM ET
- Size
- 10.4 KB